ARTICLE | Clinical News
Access Pharmaceuticals preclinical data
June 30, 2008 7:00 AM UTC
Using in vitro and mouse xenograft models, Angiolix blocked new blood vessel formation in tumors. The antibody against lactadherin is in preclinical testing as monotherapy and in combination with oth...